Crystallise’s Health Economic Modelling Service offers the pharmaceutical and healthcare industries a flexible approach to complex disease modelling and evidence-based research. Our clinical expertise and modelling capabilities allow us to provide comprehensive assessments of the impact of interventions on key health outcomes. We collaborate with economic modelling experts to ensure you receive the full range of required experience and competencies for Heath Technology Assessments.
